<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92541">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02079454</url>
  </required_header>
  <id_info>
    <org_study_id>invos0001</org_study_id>
    <nct_id>NCT02079454</nct_id>
  </id_info>
  <brief_title>Post-operative Cardiac Outcome of Non-cardiac Surgery Predicted by INVOS</brief_title>
  <official_title>Valeur Predictive de l'INVOS Sur l'Outcome Cardiaque en Post-opératoire. (French Title)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee: 40320109023</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research aimed to find a correlation with an invos drop and cardiac events in the
      peri-operative period of non cardiac surgery.

      The investigators postulate that a drop in the Invos numbers (with or without significant
      drop in BP) is associated with a variable degree of cardiac suffering.

      The idea is to prevent per and foremostpost-operative myocardial necrosis  complications by
      acting as soon as we have an INVOS drop during anesthesia.

      The &quot;cardiac events&quot; will be monitored and defined according to the EHA (european heart
      association) guidelines.

      (Changes of the EKG and/or troponin I values above the threshold). Patient will be monitored
      per and post operatively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>A composite measurement of major vascular events in the post-operative period</measure>
    <time_frame>96 hours post-operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Myocardial infarction (measured by positivation of troponin I assay above the defined threshold) associated with clinical data (pain, dyspnea,...) or ST modification on the EKG or apparition of a new LBBB, or new wall abnormalities on the TTE.
Or new TIAs or CVAs</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">34</enrollment>
  <condition>Invos</condition>
  <condition>Peri-operative</condition>
  <condition>Cardiac Outcome</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples for troponin I measurement
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patient with high cardiac comorbidities undergoing a general anesthesia for a surgery of
        over two hours with bleding potential.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female

          -  Age minimum 18 years old

        Exclusion Criteria:

          -  Chronic renal failure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>cliniques universitaires St Luc</name>
      <address>
        <city>Brussels</city>
        <state>Brabant</state>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>July 20, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
